Akzo Nobel N V ADR (AKZOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,834,534 | 1,423,520 | 3,305,619 | 1,494,257 | 1,636,661 |
| Marketable Securities | 285,575 | 154,560 | 6,448,260 | N/A | N/A |
| Receivables | 2,277,746 | 2,388,960 | 2,528,521 | 2,219,909 | 3,084,094 |
| Inventories | 1,323,926 | 1,275,680 | 1,345,159 | 1,236,548 | 1,695,311 |
| Other current assets | 62,826 | 70,560 | 87,391 | 5,270,586 | 65,290 |
| TOTAL | $5,784,607 | $5,313,280 | $13,714,950 | $10,221,300 | $6,481,356 |
| Non-Current Assets | |||||
| PPE Net | 1,851,668 | 1,904,000 | 2,064,388 | 2,070,710 | 4,636,654 |
| Investments And Advances | 0 | 168,000 | 161,797 | 133,375 | 178,163 |
| Intangibles | 4,059,734 | 4,060,000 | 4,083,898 | 3,853,193 | 4,883,426 |
| Other Non-Current Assets | 3,356,077 | 3,096,800 | 2,158,868 | 2,007,412 | 1,742,897 |
| TOTAL | $9,267,479 | $9,228,800 | $8,468,951 | $8,064,690 | $11,441,140 |
| Total Assets | $15,052,090 | $14,542,080 | $22,183,900 | $18,285,990 | $17,922,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,947,134 | 2,694,720 | 3,123,745 | 3,158,058 | 3,845,435 |
| Other current liabilities | 450,066 | 258,720 | 249,191 | 2,754,541 | 466,985 |
| TOTAL | $3,533,134 | $3,362,240 | $4,346,080 | $7,145,757 | $4,662,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,165,313 | 2,287,040 | 2,124,619 | 2,599,690 | 2,925,850 |
| Other Non-Current Liabilities | -46,834 | 1,056,160 | 996,764 | 1,008,228 | 2,053,850 |
| TOTAL | $4,722,268 | $3,823,680 | $3,620,946 | $4,011,435 | $5,476,563 |
| Total Liabilities | $8,255,402 | $7,185,920 | $7,967,026 | $11,157,190 | $10,138,670 |
| Shareholders' Equity | |||||
| Common Shares | 108,519 | 112,000 | 604,672 | 570,802 | 557,726 |
| Other shareholders' equity | 6,688,167 | 7,244,160 | 12,480,810 | 5,688,800 | 6,400,574 |
| TOTAL | $6,796,685 | $7,356,160 | $14,216,880 | $7,128,802 | $7,783,824 |
| Total Liabilities And Equity | $15,052,087 | $14,542,080 | $22,183,906 | $18,285,992 | $17,922,494 |